指南与共识神经肿瘤

儿童胶质瘤的分子分型与靶向治疗:综述与共识推荐

Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.
指南 / 共识 · Neuro Oncol · 2019-01-01

随着儿童胶质瘤关键致癌驱动基因的发现,精准诊断与治疗的角色快速演变。过去一年4项学术中心研究显示将测序纳入儿童脑肿瘤诊疗可行且有用。基于这些数据,共识推荐下一代测序应常规纳入多数儿童胶质瘤的检查。

要点

  • 下一代测序应常规纳入多数儿童胶质瘤的检查。
  • 4项研究显示将测序纳入儿童脑肿瘤诊疗可行且有用。
  • 精准诊断与治疗对儿童胶质瘤临床管理有重要意义。

核心结论

  • 主要共识推荐是下一代测序应常规纳入多数儿童胶质瘤的检查。

研究设计与样本

  • 基于4项学术中心研究及其他数据合成的综述与共识推荐。

主要发现

  • 过去一年4项学术中心研究均显示将测序纳入儿童脑肿瘤诊疗可行且有用,尤其对儿童和年轻成人胶质瘤。

关键数值与推荐

  • 主要共识推荐:下一代测序应常规纳入多数儿童胶质瘤的检查。

临床怎么用

  • 作者共识推荐将精准诊断与治疗整合进儿童神经肿瘤实践,下一代测序应常规纳入多数儿童胶质瘤的检查。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As the field of neuro-oncology makes headway in uncovering the key oncogenic drivers in pediatric glioma, the role of precision diagnostics and therapies continues to rapidly evolve with important implications for the standard of care for clinical management of these patients. Four studies at major academic centers were published in the last year outlining the clinically integrated molecular profiling and targeting of pediatric brain tumors; all 4 demonstrated the feasibility and utility of incorporating sequencing into the care of children with brain tumors, in particular for children and young adults with glioma. Based on synthesis of the data from these studies and others, we provide consensus recommendations for the integration of precision diagnostics and therapeutics into the practice of pediatric neuro-oncology. Our primary consensus recommendation is that next-generation sequencing should be routinely included in the workup of most pediatric gliomas.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Miklja Z, Pasternak A, Stallard S, et al. Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations. Neuro Oncol. 2019. PMID: 30805642. doi:10.1093/neuonc/noz022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。